Last 12 months
Inside the activity.
22 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 6 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 10 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 6 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock Options · Derivative | 17,360 | $0.00 Strike: $15.25 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 17 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 695 Underlying: Common Stock · 17,360 shares Expires 2027-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 11/13/2018, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 11/13/2020. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock Options · Derivative | 4,583 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 16 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139 Underlying: Common Stock · 4,583 shares Expires 2027-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 03/21/2018, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 03/21/2020. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock Options · Derivative | 9,000 | $0.00 Strike: $7.36 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 15 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,000 shares Expires 2026-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options granted became exercisable as follows: 1/3 on 04/04/2017, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted became exercisable on 04/04/2019. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock Options · Derivative | 15,000 | $0.00 Strike: $7.35 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 14 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2025-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These stock options became exercisable in three equal annual installments on April 7, 2016, April 7, 2017, and April 7, 2018. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock Options · Derivative | 10,000 | $0.00 Strike: $15.54 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 13 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These stock options became exercisable in three equal annual installments on March 7, 2015, March 7, 2016, and March 7, 2017. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock Options · Derivative | 20,000 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 12 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2023-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These stock options became exercisable in three equal annual installments on March 4, 2014, March 4, 2015, and March 4, 2016. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock Options · Derivative | 20,000 | $0.00 Strike: $11.00 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 11 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These stock options became exercisable in three equal annual installments on March 4, 2014, March 4, 2015, and March 4, 2016. F3 · derivative.exercise_date: These stock options became exercisable in three equal annual installments on March 2, 2013, March 2, 2014, and March 2, 2015. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
SaleCommon Stock | 106,604 | $42.20 | $4,498,688.80 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 10 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,101 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.86 to $42.53, inclusive. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock | 3,370 | $29.80 | $100,426.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 9 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock | 7,291 | $16.15 | $117,749.65 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 8 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock | 17,360 | $15.25 | $264,740.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 7 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock | 4,583 | $9.30 | $42,621.90 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 6 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock | 9,000 | $7.36 | $66,240.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 5 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock | 15,000 | $7.35 | $110,250.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 4 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock | 10,000 | $15.54 | $155,400.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 3 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock | 20,000 | $5.34 | $106,800.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 2 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
Exercise / conversionCommon Stock | 20,000 | $11.00 | $220,000.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 26, 2021 22:28 UTC |
Yu K PeonyDirector
|
GrantCommon Stock | 318 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-005474 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318 Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 00:00 UTC |
BROADWOOD PARTNERS, L.P.10% owner
BROADWOOD CAPITAL INC10% owner
Bradsher Neal C10% owner
|
OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000919574-20-000075 · ownership.xml · nonDerivative · entry 2 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnote Disclosed balance after: 10,799,410 F1 · kind: The shares were transferred to a limited partner of Broadwood Partners, L.P. No shares were sold by Broadwood Partners, L.P. F1 · price: The shares were transferred to a limited partner of Broadwood Partners, L.P. No shares were sold by Broadwood Partners, L.P. F3 · ownership.nature: The reported securities are directly owned by Broadwood Partners, L.P. and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners, L.P. and Neal C. Bradsher as President of Broadwood Capital, Inc. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 00:00 UTC |
BROADWOOD PARTNERS, L.P.10% owner
BROADWOOD CAPITAL INC10% owner
Bradsher Neal C10% owner
|
OtherCommon Stock | 41,220 | $0.00 | $0.00 |
DisclosureSEC source: 0000919574-20-000075 · ownership.xml · nonDerivative · entry 1 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,799,410 F1 · kind: The shares were transferred to a limited partner of Broadwood Partners, L.P. No shares were sold by Broadwood Partners, L.P. F1 · price: The shares were transferred to a limited partner of Broadwood Partners, L.P. No shares were sold by Broadwood Partners, L.P. F2 · ownership.direct: These securities are owned by Broadwood Partners, L.P., which is a Reporting Person. Read SEC document |
| December 13, 2019 Filed Dec 13, 2019 21:06 UTC |
Wall William PDirector
|
Disposition to issuerCommon Stock | 4,000 | $37.40 | $149,600.00 |
DisclosureSEC source: 0001209191-19-060345 · doc4.xml · nonDerivative · entry 1 Wall William P · CIK 0001393025 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,489 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.40 to $37.41, inclusive. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 21:35 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock Options · Derivative | 32,335 | $0.00 Strike: $8.64 | $0.00 |
DisclosureSEC source: 0001209191-19-059485 · doc4.xml · derivative · entry 4 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,665 Underlying: Common Stock Options · 32,335 shares Expires 2025-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested in three equal installments on July 27, 2016, July 27, 2017, and July 27, 2018. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 21:35 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
SaleCommon Stock | 15,073 | $37.31 | $562,373.63 |
DisclosureSEC source: 0001209191-19-059485 · doc4.xml · nonDerivative · entry 3 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.55, inclusive. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 21:35 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
SaleCommon Stock | 32,335 | $37.15 | $1,201,245.25 |
DisclosureSEC source: 0001209191-19-059485 · doc4.xml · nonDerivative · entry 2 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,323 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.33, inclusive. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 21:35 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock | 32,335 | $8.64 | $279,374.40 |
DisclosureSEC source: 0001209191-19-059485 · doc4.xml · nonDerivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 21:34 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
Exercise / conversionCommon Stock Options · Derivative | 20,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001209191-19-059482 · doc4.xml · derivative · entry 6 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2021-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested in three equal installments on March 15, 2012, March 15, 2013, and March 15, 2014. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 21:34 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
Exercise / conversionCommon Stock Options · Derivative | 25,000 | $0.00 Strike: $5.68 | $0.00 |
DisclosureSEC source: 0001209191-19-059482 · doc4.xml · derivative · entry 5 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2020-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested in three equal installments on December 15, 2011, December 15, 2012, and December 15, 2013. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 21:34 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
SaleCommon Stock | 20,000 | $38.15 | $763,000.00 |
DisclosureSEC source: 0001209191-19-059482 · doc4.xml · nonDerivative · entry 4 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,200 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.33, inclusive. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 21:34 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
Exercise / conversionCommon Stock | 20,000 | $5.49 | $109,800.00 |
DisclosureSEC source: 0001209191-19-059482 · doc4.xml · nonDerivative · entry 3 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 21:34 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
SaleCommon Stock | 25,000 | $38.15 | $953,750.00 |
DisclosureSEC source: 0001209191-19-059482 · doc4.xml · nonDerivative · entry 2 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,200 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.33, inclusive. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 21:34 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
Exercise / conversionCommon Stock | 25,000 | $5.68 | $142,000.00 |
DisclosureSEC source: 0001209191-19-059482 · doc4.xml · nonDerivative · entry 1 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:33 UTC |
Moore John CDirector
|
Exercise / conversionCommon Stock Options · Derivative | 20,000 | $0.00 Strike: $4.73 | $0.00 |
DisclosureSEC source: 0001209191-19-058128 · doc4.xml · derivative · entry 4 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2020-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:33 UTC |
Moore John CDirector
|
Exercise / conversionCommon Stock | 8,613 | $38.54 | $331,945.02 |
DisclosureSEC source: 0001209191-19-058128 · doc4.xml · nonDerivative · entry 2 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.50 to $38.61, inclusive. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:33 UTC |
Moore John CDirector
|
Exercise / conversionCommon Stock | 20,000 | $4.73 | $94,600.00 |
DisclosureSEC source: 0001209191-19-058128 · doc4.xml · nonDerivative · entry 1 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2019 Filed Nov 22, 2019 21:59 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock Options · Derivative | 4,862 | $7.52 Strike: $7.52 | $36,562.24 |
DisclosureSEC source: 0001209191-19-057821 · doc4.xml · derivative · entry 5 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,862 shares Expires 2026-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options granted became exercisable as follows: 1/3 on 3/18/2017 and 2/3 of such options became exercisable over the following 24 months in equal amounts on a monthly basis. Read SEC document |
| November 22, 2019 Filed Nov 22, 2019 21:59 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock Options · Derivative | 9,076 | $9.30 Strike: $9.30 | $84,406.80 |
DisclosureSEC source: 0001209191-19-057821 · doc4.xml · derivative · entry 4 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,881 Underlying: Common Stock · 9,076 shares Expires 2027-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options granted became exercisable as follows: 1/3 on 3/21/2018 and the remaining 2/3 of such options became exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/21/2020. Read SEC document |
| November 22, 2019 Filed Nov 22, 2019 21:59 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock | 4,862 | $7.52 | $36,562.24 |
DisclosureSEC source: 0001209191-19-057821 · doc4.xml · nonDerivative · entry 3 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,272 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2019 Filed Nov 22, 2019 21:59 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
Exercise / conversionCommon Stock | 9,076 | $9.30 | $84,406.80 |
DisclosureSEC source: 0001209191-19-057821 · doc4.xml · nonDerivative · entry 2 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 21:59 UTC |
Hansen Graydon C.Sr. VP, Global Operations
|
SaleCommon Stock | 17,083 | $35.02 | $598,246.66 |
DisclosureSEC source: 0001209191-19-057821 · doc4.xml · nonDerivative · entry 1 Hansen Graydon C. · CIK 0001781933 · Sr. VP, Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,334 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.05, inclusive. F2 · balance_after: Reflects Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 6,250 RSUs on March 21, 2020, and lapse as to 2,084 RSUs on November 13, 2020. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 21:15 UTC |
ANDREWS DEBORAH JChief Financial Officer
|
SaleCommon Stock | 4,167 | $34.68 | $144,511.56 |
DisclosureSEC source: 0001209191-19-056725 · doc4.xml · nonDerivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,101 Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 21:12 UTC |
Barnes Scott DChief Medical Officer
|
SaleCommon Stock | 1,583 | $34.93 | $55,294.19 |
DisclosureSEC source: 0001209191-19-056718 · doc4.xml · nonDerivative · entry 1 Barnes Scott D · CIK 0001781830 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,032 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.93 to $34.95, inclusive. Read SEC document |
| November 05, 2019 Filed Nov 6, 2019 21:26 UTC |
Holliday KeithChief Technology Officer
|
SaleCommon Stock | 14,441 | $35.00 | $505,435.00 |
DisclosureSEC source: 0001209191-19-055495 · doc4.xml · nonDerivative · entry 2 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,323 Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:26 UTC |
Holliday KeithChief Technology Officer
|
SaleCommon Stock | 2,100 | $35.00 | $73,500.00 |
DisclosureSEC source: 0001209191-19-055495 · doc4.xml · nonDerivative · entry 1 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,764 Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 21:24 UTC |
FARRELL STEPHEN CDirector
|
GrantCommon Stock Options · Derivative | 8,536 | $0.00 Strike: $29.39 | $0.00 |
DisclosureSEC source: 0001209191-19-038819 · doc4.xml · derivative · entry 1 FARRELL STEPHEN C · CIK 0001188757 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,536 Underlying: Common Stock · 8,536 shares Expires 2029-06-19 F1 · derivative.exercise_date: These stock options vest in full on the earlier of June 20, 2020 or the Corporation's 2020 Annual Meeting, subject to Mr. Farrell's continued service through the vesting date. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 21:23 UTC |
SILVERMAN LOUDirector
|
GrantCommon Stock Options · Derivative | 4,268 | $0.00 Strike: $29.39 | $0.00 |
DisclosureSEC source: 0001209191-19-038818 · doc4.xml · derivative · entry 3 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,268 Underlying: Common Stock · 4,268 shares Expires 2029-06-19 F3 · derivative.exercise_date: These stock options vest in full on the earlier of June 20, 2020 or the Corporation's 2020 Annual Meeting, subject to Mr. Silverman's continued service through the vesting date. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 21:23 UTC |
SILVERMAN LOUDirector
|
GrantCommon Stock | 2,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-038818 · doc4.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,733 F1 · shares: The restrictions on the 2,127 restricted shares of common stock lapse on the earlier of June 20, 2020 or the Corporation's 2020 Annual Meeting, subject to Mr. Silverman's continued service through that date. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 21:22 UTC |
Moore John CDirector
|
GrantCommon Stock | 4,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-038816 · doc4.xml · nonDerivative · entry 1 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,289 F1 · shares: The restrictions on the 4,254 restricted shares of common stock lapse on the earlier of June 20, 2020 or the Corporation's 2020 Annual Meeting, subject to Mr. Moore's continued service through that date. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 21:21 UTC |
Wall William PDirector
|
GrantCommon Stock | 4,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-038815 · doc4.xml · nonDerivative · entry 1 Wall William P · CIK 0001393025 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,489 F1 · shares: The restrictions on the 4,254 restricted shares of common stock lapse on the earlier of June 20, 2020 or the Corporation's 2020 Annual Meeting, subject to Mr. Wall's continued service through that date. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:00 UTC |
Moore John CDirector
|
Exercise / conversionCommon Stock · Derivative | 7,500 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0001209191-19-028213 · doc4.xml · derivative · entry 3 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2019-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:00 UTC |
Moore John CDirector
|
Exercise / conversionCommon Stock | 7,500 | $1.92 | $14,400.00 |
DisclosureSEC source: 0001209191-19-028213 · doc4.xml · nonDerivative · entry 1 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.